Dr. Mohamad Khawandanah
Claim this profileUniversity of Oklahoma Health Sciences Center
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Myeloid Leukemia
11 reported clinical trials
33 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
13q positive
13q negative
12 positive
2Myeloid Leukemia
BCR/ABL negative
BCR/ABL positive
BCR-ABL positive
Affiliated Hospitals
Clinical Trials Mohamad Khawandanah is currently running
Venetoclax + HMA
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug that is absorbed into DNA and leads to the activation of cancer suppressor genes, which are genes that help control cell growth. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This study may help doctors find out if these different approaches are better than the usual approaches. To decide if they are better, the study doctors are looking to see if the study drugs lead to a higher percentage of patients achieving a deeper remission compared to the usual approach.
Recruiting1 award Phase 27 criteria
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
More about Mohamad Khawandanah
Clinical Trial Related7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Mohamad Khawandanah has experience with
- Dexamethasone
- Cyclophosphamide
- Doxorubicin
- Inotuzumab Ozogamicin
- Methotrexate
- Rituximab
Breakdown of trials Mohamad Khawandanah has run
T-Lymphoblastic Leukemia/Lymphoma
Myeloid Leukemia
Lymphoid Leukemia
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohamad Khawandanah specialize in?
Mohamad Khawandanah focuses on T-Lymphoblastic Leukemia/Lymphoma and Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved 13q positive patients, or patients who are 13q negative.
Is Mohamad Khawandanah currently recruiting for clinical trials?
Yes, Mohamad Khawandanah is currently recruiting for 5 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Mohamad Khawandanah has studied deeply?
Yes, Mohamad Khawandanah has studied treatments such as Dexamethasone, Cyclophosphamide, Doxorubicin.
What is the best way to schedule an appointment with Mohamad Khawandanah?
Apply for one of the trials that Mohamad Khawandanah is conducting.
What is the office address of Mohamad Khawandanah?
The office of Mohamad Khawandanah is located at: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the University of Oklahoma Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.